US5714352A
(en)
*
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
TWI335336B
(de)
*
|
2000-02-10 |
2011-01-01 |
Abbott Gmbh & Co Kg |
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
WO2002046208A2
(en)
*
|
2000-11-01 |
2002-06-13 |
Elusys Therapeutics, Inc. |
Method of producing biospecific molecules by protein trans-splicing
|
WO2002051438A2
(en)
|
2000-12-22 |
2002-07-04 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
PE20020801A1
(es)
*
|
2001-01-05 |
2002-09-06 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina
|
US20040221327A1
(en)
*
|
2001-03-27 |
2004-11-04 |
Gershwin M. Eric |
Antibodies against autoantigens of primary billary cirrhosis and methods of making and using them
|
WO2002085924A2
(en)
*
|
2001-04-23 |
2002-10-31 |
Abgenix, Inc. |
ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE
|
EP1463522A4
(de)
*
|
2001-05-16 |
2005-04-13 |
Einstein Coll Med |
Humane antipneumokokken-antikörper von nichthumanen tieren
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
IL161863A0
(en)
*
|
2001-11-09 |
2005-11-20 |
Neopharm Inc |
Selective treatment of il-13 expressing tumors
|
ES2624547T3
(es)
|
2001-11-14 |
2017-07-14 |
Janssen Biotech, Inc. |
Anticuerpos anti il 6, composiciones, métodos y usos
|
WO2003052082A2
(en)
*
|
2001-12-18 |
2003-06-26 |
Whitehead Institute For Biomedical Research |
Fusion partner cells and uses thereof
|
SI1527100T1
(sl)
*
|
2002-03-29 |
2009-12-31 |
Schering Corp |
Humana monoklonska protitelesa proti interlevkinu-5 in postopki in sestavki, ki jih obsegajo
|
US20050121254A1
(en)
*
|
2002-05-29 |
2005-06-09 |
Marcus Hofmann |
Device for establishing noise in a motor vehicle
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
EP1596813A4
(de)
*
|
2003-01-31 |
2008-02-20 |
Five Prime Therapeutics Inc |
In der lunge exprimierte polypeptide
|
WO2004087758A2
(en)
*
|
2003-03-26 |
2004-10-14 |
Neopharm, Inc. |
Il 13 receptor alpha 2 antibody and methods of use
|
CR20120384A
(es)
*
|
2003-05-14 |
2016-12-02 |
Immunogen Inc |
Composición de farmaco conjugado
|
HN2004000285A
(es)
*
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
FR2861255B1
(fr)
*
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
US20050100965A1
(en)
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
MX370489B
(es)
|
2004-01-09 |
2019-12-16 |
Pfizer |
Anticuerpos contra madcam.
|
EP2369014A1
(de)
|
2004-02-03 |
2011-09-28 |
The Regents Of The University Of Michigan Office Of Technology Transfer |
Zusammensetzungen und Verfahren zur Charakterisierung, Regulierung, Diagnose und Behandlung von Krebs
|
AU2005259221B2
(en)
|
2004-07-01 |
2011-02-10 |
Innate Pharma |
Antibodies binding to receptors KIR2DL1, -2, 3 but not KIR2DS4 and their therapeutic use
|
KR20080019733A
(ko)
*
|
2004-07-16 |
2008-03-04 |
화이자 프로덕츠 인코포레이티드 |
항-아이지에프-1알 항체를 사용하는 비-혈액학적악성종양에 대한 조합 치료
|
EP2468304A3
(de)
|
2005-02-11 |
2012-09-26 |
ImmunoGen, Inc. |
Verfahren zum Herstellen von stabilen Arzneimittelkonjugaten
|
US20110166319A1
(en)
*
|
2005-02-11 |
2011-07-07 |
Immunogen, Inc. |
Process for preparing purified drug conjugates
|
NZ560844A
(en)
|
2005-03-08 |
2008-08-29 |
Pharmacia & Upjohn Co Llc |
Anti-MAdCAM antibody compositions
|
EA201100642A1
(ru)
*
|
2005-04-25 |
2011-12-30 |
Пфайзер Инк. |
Антитела к миостатину
|
MX2007013304A
(es)
|
2005-04-26 |
2007-12-13 |
Pfizer |
Anticuerpos de p-caderina.
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
CN103172738A
(zh)
*
|
2005-06-30 |
2013-06-26 |
Abbvie公司 |
Il-12/p40结合蛋白
|
US7491391B2
(en)
|
2005-06-30 |
2009-02-17 |
Centocor, Inc. |
Anti-IL-23 antibodies, compositions, methods and uses
|
NZ599176A
(en)
*
|
2005-08-03 |
2014-04-30 |
Immunogen Inc |
Immunoconjugate formulations
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
WO2007024715A2
(en)
|
2005-08-19 |
2007-03-01 |
Abbott Laboratories |
Dual variable domain immunoglobin and uses thereof
|
US20090215992A1
(en)
*
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
EP2500354A3
(de)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
SI1928503T1
(sl)
|
2005-08-24 |
2012-11-30 |
Immunogen Inc |
Postopek za pripravo konjugatov majtansinoid protitelo
|
PL2447283T3
(pl)
|
2005-09-07 |
2015-12-31 |
Amgen Fremont Inc |
Ludzkie przeciwciała monoklonalne przeciwko kinazie podobnej do receptora aktywiny-1 (ALK-1)
|
AU2006287315B2
(en)
|
2005-09-09 |
2013-02-21 |
The Johns Hopkins University |
Manipulation of regulatory T cell and DC function by targeting neuritin gene using antibodies, agonists and antagonists
|
CA2624562A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Abbott Gmbh & Co. Kg |
Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use
|
WO2007055902A1
(en)
*
|
2005-11-03 |
2007-05-18 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Immunogenic peptides and methods of use for treating and preventing cancer
|
CA2631195C
(en)
*
|
2005-11-30 |
2016-04-05 |
Abbott Laboratories |
Monoclonal antibodies against amyloid beta protein and uses thereof
|
CN101432302A
(zh)
*
|
2005-11-30 |
2009-05-13 |
艾博特公司 |
抗-Aβ球聚体抗体,其抗原结合部分,相应的杂交瘤、核酸、载体、宿主细胞,生产所述抗体的方法,包含所述抗体的组合物,所述抗体的应用以及使用所述抗体的方法
|
US8014957B2
(en)
*
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
ES2622602T3
(es)
|
2005-12-29 |
2017-07-06 |
Janssen Biotech, Inc. |
Anticuerpos anti-IL-23 humanos, composiciones, procedimientos y usos
|
US7820174B2
(en)
|
2006-02-24 |
2010-10-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
T cell receptors and related materials and methods of use
|
EP2054444B1
(de)
|
2006-08-04 |
2016-11-02 |
MedImmune Limited |
Antikörper gegen erbb2
|
KR101544108B1
(ko)
|
2006-09-08 |
2015-08-13 |
애브비 바하마스 리미티드 |
인터루킨-13 결합 단백질
|
WO2008039818A2
(en)
|
2006-09-26 |
2008-04-03 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified t cell receptors and related materials and methods
|
EP2094282A4
(de)
*
|
2006-11-15 |
2010-05-05 |
Functional Genetics Inc |
Antikörper gegen tsg101 und verwendungen davon zur behandlung von virusinfektionen
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
AU2008206442B2
(en)
|
2007-01-12 |
2012-10-18 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
gp100-specific T cell receptors and related materials and methods of use
|
US8435752B2
(en)
*
|
2007-01-18 |
2013-05-07 |
University Of Southern California |
Gene polymorphisms predictive for dual TKI therapy
|
EP2124952A2
(de)
*
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Verfahren zur behandlung von amyloidosen
|
CA2682927A1
(en)
*
|
2007-04-02 |
2008-10-16 |
Amgen Fremont Inc. |
Anti-ige antibodies
|
US20090175847A1
(en)
*
|
2007-05-30 |
2009-07-09 |
Abbott Laboratories |
Humanized antibodies to ab (20-42) globulomer and uses thereof
|
US20090232801A1
(en)
*
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
DK3078743T3
(da)
|
2007-09-28 |
2020-08-10 |
Portola Pharm Inc |
Antidoter til faktor xa-inhibitorer og fremgangsmåder til anvendelse af disse
|
EP2214708A4
(de)
|
2007-10-26 |
2011-01-12 |
Centocor Ortho Biotech Inc |
Vektoren, wirtszellen und herstellungsverfahren und verwendungen
|
US8962803B2
(en)
*
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
KR20110014607A
(ko)
|
2008-04-29 |
2011-02-11 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
US20100260668A1
(en)
*
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
WO2009136382A2
(en)
*
|
2008-05-09 |
2009-11-12 |
Abbott Gmbh & Co. Kg |
Antibodies to receptor of advanced glycation end products (rage) and uses thereof
|
MX2010013239A
(es)
*
|
2008-06-03 |
2011-02-24 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
UY31861A
(es)
|
2008-06-03 |
2010-01-05 |
Abbott Lab |
Inmunoglobulina con dominio variable dual y usos de la misma
|
RU2559525C2
(ru)
|
2008-07-08 |
2015-08-10 |
Эббви Инк |
Белки, связывающие простагландин е2, и их применение
|
MX2010014574A
(es)
*
|
2008-07-08 |
2011-04-27 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual para prostaglandina e2 y usos de las mismas.
|
JP5362828B2
(ja)
*
|
2008-07-15 |
2013-12-11 |
カーディアック ペースメイカーズ, インコーポレイテッド |
音響的にイネーブルされる埋め込み型医療デバイス用のインプラント補助装置
|
SG10201701323TA
(en)
|
2008-08-18 |
2017-04-27 |
Amgen Fremont Inc |
Antibodies to ccr2
|
SG171812A1
(en)
*
|
2008-12-04 |
2011-07-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
US20110165063A1
(en)
*
|
2009-01-29 |
2011-07-07 |
Abbott Laboratories |
Il-1 binding proteins
|
SG172855A1
(en)
*
|
2009-01-29 |
2011-08-29 |
Abbott Lab |
Il-1 binding proteins
|
WO2010091328A1
(en)
|
2009-02-09 |
2010-08-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Diagnostic and therapeutic uses of gnptab, gnptg, and nagpa in stuttering
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
NZ611324A
(en)
|
2009-03-05 |
2015-02-27 |
Abbvie Inc |
Il-17 binding proteins
|
EP3604510A1
(de)
|
2009-03-30 |
2020-02-05 |
Portola Pharmaceuticals, Inc. |
Gegenmittel für faktor-xa-inhibitoren und verfahren zur verwendung davon
|
TR201907573T4
(tr)
|
2009-06-03 |
2019-06-21 |
Immunogen Inc |
Konjugasyon yöntemleri̇
|
US20120121589A1
(en)
|
2009-07-13 |
2012-05-17 |
Wayne State University |
Modified egfr ectodomain
|
PT2453910T
(pt)
|
2009-07-15 |
2016-12-07 |
Portola Pharm Inc |
Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
|
UY32808A
(es)
*
|
2009-07-29 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas como dominio variable dual y usos de las mismas
|
US9259476B2
(en)
|
2009-07-31 |
2016-02-16 |
Wayne State University |
Monophosphorylated lipid A derivatives
|
WO2011014771A1
(en)
|
2009-07-31 |
2011-02-03 |
Wayne State University |
Monophosphorylated lipid a derivatives
|
PE20121647A1
(es)
*
|
2009-08-29 |
2012-12-31 |
Abbvie Inc |
Proteinas terapeuticas de union a dll4
|
UY32870A
(es)
|
2009-09-01 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
JP5934099B2
(ja)
|
2009-10-01 |
2016-06-15 |
アメリカ合衆国 |
抗血管内皮増殖因子受容体−2キメラ抗原受容体及び癌の治療のためのその使用
|
RU2012119756A
(ru)
|
2009-10-15 |
2013-11-20 |
Эбботт Лэборетриз |
Иммуноглобулины с двумя вариабельными доменами и их применение
|
UY32979A
(es)
*
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
TW201121568A
(en)
|
2009-10-31 |
2011-07-01 |
Abbott Lab |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
WO2011070045A1
(en)
|
2009-12-08 |
2011-06-16 |
Abbott Gmbh & Co. Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
US9056068B2
(en)
|
2010-02-04 |
2015-06-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Vaccine and methods of use against Strongyloide stercoralis infection
|
CN102933231B
(zh)
|
2010-02-10 |
2015-07-29 |
伊缪诺金公司 |
Cd20抗体及其用途
|
KR101637138B1
(ko)
|
2010-02-24 |
2016-07-06 |
이뮤노젠 아이엔씨 |
엽산염 수용체 1 항체와 면역접합체 및 이들의 용도
|
WO2011109298A2
(en)
|
2010-03-02 |
2011-09-09 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
EP2547359B1
(de)
|
2010-03-15 |
2016-03-09 |
The Board of Trustees of the University of Illionis |
Hemmer von interaktionen, die beta-integrin-g protein-alpha-untereinheit binden
|
WO2011119906A1
(en)
|
2010-03-26 |
2011-09-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HUMAN POLYOMAVIRUS 6 (HPyV6) AND HUMAN POLYOMAVIRUS 7 (HPyV7)
|
BR112012024786A2
(pt)
|
2010-03-30 |
2017-01-10 |
Janssen Biotech Inc |
anticorpos humanizados il-25
|
WO2011123518A1
(en)
|
2010-03-31 |
2011-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
UY33386A
(es)
|
2010-05-14 |
2011-12-30 |
Abbott Laboratoires |
Proteínas de unión a il-1
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
JP6482757B2
(ja)
|
2010-07-26 |
2019-03-13 |
トリアンニ インコーポレイテッドTrianni,Inc. |
トランスジェニック動物および使用方法
|
US10793829B2
(en)
|
2010-07-26 |
2020-10-06 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
US10662256B2
(en)
|
2010-07-26 |
2020-05-26 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
TW201206473A
(en)
|
2010-08-03 |
2012-02-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
MX358739B
(es)
|
2010-08-14 |
2018-09-03 |
Abbvie Inc Star |
Proteinas de union a amiloide beta.
|
SI3333188T1
(sl)
|
2010-08-19 |
2022-04-29 |
Zoetis Belgium S.A. |
Protitelesa proti NGF in njihova uporaba
|
JP2013539364A
(ja)
|
2010-08-26 |
2013-10-24 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリンおよびその使用
|
EP3533802B1
(de)
|
2010-09-21 |
2021-03-17 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Anti-ssx-2-t-zell-rezeptoren und zugehörige materialien sowie verwendungsverfahren
|
WO2012054825A1
(en)
|
2010-10-22 |
2012-04-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mage-a3 t cell receptors and related materials and methods of use
|
WO2012061281A1
(en)
|
2010-11-04 |
2012-05-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Diagnostic assays and methods of use for detection of filarial infection
|
WO2012087943A2
(en)
|
2010-12-20 |
2012-06-28 |
The Regents Of The University Of Michigan |
Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
|
JP6009455B2
(ja)
|
2010-12-21 |
2016-10-19 |
アッヴィ・インコーポレイテッド |
Il−1アルファおよびベータ二重特異的二重可変ドメイン免疫グロブリンおよびその使用
|
WO2012088094A2
(en)
|
2010-12-21 |
2012-06-28 |
Abbott Laboratories |
Il-1 binding proteins
|
ES2899186T3
(es)
|
2010-12-31 |
2022-03-10 |
Bioatla Inc |
Humanización rápida de anticuerpos
|
KR20220009505A
(ko)
|
2011-03-29 |
2022-01-24 |
이뮤노젠 아이엔씨 |
일-단계 방법에 의한 메이탄시노이드 항체 접합체의 제조
|
WO2012135517A2
(en)
|
2011-03-29 |
2012-10-04 |
Immunogen, Inc. |
Preparation of maytansinoid antibody conjugates by a one-step process
|
US9266960B2
(en)
|
2011-04-08 |
2016-02-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
|
US9346859B2
(en)
|
2011-06-09 |
2016-05-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
|
JP2014520847A
(ja)
|
2011-07-13 |
2014-08-25 |
アッヴィ・インコーポレイテッド |
抗il−13抗体を使用して喘息を治療するための方法および組成物
|
US20140378389A1
(en)
|
2011-09-15 |
2014-12-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
|
EP3301110A1
(de)
|
2011-09-16 |
2018-04-04 |
The USA, as represented by The Secretary, Department of Health and Human Services |
Pseudomonas exotoxin a mit weniger immunogenen b-zellepitopen
|
WO2013052933A2
(en)
|
2011-10-06 |
2013-04-11 |
The Board Of Trustees Of The University Of Illinois |
Myosin binding protein-c for use in methods relating to diastolic heart failure
|
JP6267644B2
(ja)
|
2011-10-20 |
2018-01-24 |
アメリカ合衆国 |
抗cd22キメラ抗原受容体
|
EP2771360A1
(de)
|
2011-10-24 |
2014-09-03 |
AbbVie Inc. |
Gegen sclerostin gerchtet immunbinder
|
AU2012328921B2
(en)
|
2011-10-24 |
2017-05-11 |
Abbvie Inc. |
Immunobinders directed against TNF
|
CA2856149A1
(en)
|
2011-11-08 |
2013-05-16 |
Pfizer Inc. |
Methods of treating inflammatory disorders using anti-m-csf antibodies
|
BR112014012539B1
(pt)
|
2011-11-23 |
2022-12-20 |
Medimmune, Llc |
Anticorpo que se liga especificamente a her3, composição compreendendo o mesmo, e usos do anticorpo
|
MX356933B
(es)
|
2011-12-14 |
2018-06-20 |
Abbvie Deutschland |
Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
|
CA2855840C
(en)
|
2011-12-14 |
2023-08-29 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
MX2014008101A
(es)
|
2011-12-30 |
2014-09-25 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra il-13 y/o il-17.
|
LT2804878T
(lt)
|
2012-01-20 |
2018-12-10 |
Genzyme Corporation |
Anti-cxcr3 antikūnai
|
NZ714482A
(en)
|
2012-01-27 |
2017-08-25 |
Abbvie Inc |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
MX2014010750A
(es)
|
2012-03-08 |
2015-02-05 |
Halozyme Inc |
Anticuerpos receptores del factor de crecimiento anti-epidermico condicionalmente activos y metodos de uso de los mismos.
|
EP2825191B1
(de)
|
2012-03-16 |
2019-08-28 |
University Health Network |
Lösliches toso protein und dessen verwendung zur behandlung von autoimmunerkrankungen
|
CA3209571A1
(en)
|
2012-03-23 |
2013-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
EP2836514A4
(de)
|
2012-04-13 |
2015-12-30 |
Childrens Medical Center |
Tiki-inhibitoren
|
EP3527584B8
(de)
|
2012-05-22 |
2020-12-16 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Medizinische verwendung von zellen die anti-ny-eso-1 t-zellrezeptoren beinhalten
|
CA2875783C
(en)
|
2012-06-06 |
2018-12-11 |
Zoetis Llc |
Caninized anti-ngf antibodies and methods thereof
|
AR091755A1
(es)
|
2012-07-12 |
2015-02-25 |
Abbvie Inc |
Proteinas de union a il-1
|
KR20200079565A
(ko)
|
2012-08-31 |
2020-07-03 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
EP3636665B1
(de)
|
2012-09-14 |
2022-06-29 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
T-zell-rezeptoren zur erkennung von mhc-klasse-ii-beschränktem mage-a3
|
US10035817B2
(en)
|
2012-10-04 |
2018-07-31 |
Immunogen, Inc. |
Method of purifying cell-binding agent-cytotoxic agent conjugates with a PVDF membrane
|
RU2658485C2
(ru)
|
2012-10-24 |
2018-06-21 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы м971
|
TW201811825A
(zh)
|
2012-11-01 |
2018-04-01 |
美商艾伯維有限公司 |
抗-vegf/dll4雙重可變區域免疫球蛋白及其用途
|
US8975033B2
(en)
|
2012-11-05 |
2015-03-10 |
The Johns Hopkins University |
Human autoantibodies specific for PAD3 which are cross-reactive with PAD4 and their use in the diagnosis and treatment of rheumatoid arthritis and related diseases
|
WO2014100542A1
(en)
|
2012-12-21 |
2014-06-26 |
Abbvie, Inc. |
High-throughput antibody humanization
|
JP6739329B2
(ja)
|
2013-03-14 |
2020-08-12 |
アボット・ラボラトリーズAbbott Laboratories |
Hcvコア脂質結合ドメインモノクローナル抗体
|
MX362075B
(es)
|
2013-03-14 |
2019-01-07 |
Abbott Lab |
Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
|
CN105452292A
(zh)
|
2013-03-14 |
2016-03-30 |
帕卡什·吉尔 |
使用结合细胞表面grp78的抗体进行癌症治疗
|
CA2906407A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
|
TW201512219A
(zh)
|
2013-03-15 |
2015-04-01 |
Abbvie Inc |
針對IL-1β及/或IL-17之雙特異性結合蛋白
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
WO2014160627A1
(en)
|
2013-03-25 |
2014-10-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 polypeptides, proteins, and chimeric antigen receptors
|
EP3003372B1
(de)
|
2013-06-07 |
2019-10-09 |
Duke University |
Inhibitoren des komplementfaktors h
|
US9890369B2
(en)
|
2013-06-20 |
2018-02-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor
|
JP6628719B2
(ja)
|
2013-07-15 |
2020-01-15 |
アメリカ合衆国 |
抗ヒトパピローマウイルス16 e6 t細胞受容体
|
SG10201907501QA
(en)
|
2013-08-30 |
2019-10-30 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
CA2922562A1
(en)
|
2013-09-12 |
2015-03-19 |
Halozyme, Inc. |
Modified anti-epidermal growth factor receptor antibodies and methods of use thereof
|
AU2014329437B2
(en)
|
2013-10-06 |
2018-10-18 |
F. Hoffmann-La Roche Ag |
Modified Pseudomonas exotoxin A
|
CA2932424C
(en)
|
2013-12-06 |
2023-10-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same
|
EP4043493A1
(de)
|
2013-12-24 |
2022-08-17 |
Janssen Pharmaceutica NV |
Anti-vista-antikörper und -fragmente
|
CA2936346A1
(en)
|
2014-01-08 |
2015-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody targeting cell surface deposited complement protein c3d and use thereof
|
CA2936984A1
(en)
|
2014-01-24 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-ny-br-1 polypeptides, proteins, and chimeric antigen receptors
|
US11648335B2
(en)
|
2014-01-31 |
2023-05-16 |
Wake Forest University Health Sciences |
Organ/tissue decellularization, framework maintenance and recellularization
|
WO2015120187A1
(en)
|
2014-02-05 |
2015-08-13 |
The University Of Chicago |
Chimeric antigen receptors recognizing cancer-spevific tn glycopeptide variants
|
CA2941693A1
(en)
|
2014-03-07 |
2015-09-11 |
University Health Network |
Methods and compositions for detection of targets involved in cancer metastasis
|
SG10201913627TA
(en)
|
2014-04-08 |
2020-03-30 |
Boston Pharmaceuticals Inc |
Binding molecules specific for il-21 and uses thereof
|
RU2016144176A
(ru)
|
2014-04-11 |
2018-05-14 |
МЕДИММЬЮН, ЭлЭлСи |
Биспецифические антитела к her2
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
IL290655B2
(en)
|
2014-05-29 |
2024-05-01 |
Us Health |
Anti-human papillomavirus 16 E7 T-cell chelates
|
WO2016003893A1
(en)
|
2014-06-30 |
2016-01-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Detection of colorectal cancer with two novel heme-related molecules in human feces
|
CA2961609C
(en)
|
2014-09-17 |
2023-03-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 antibodies (b7h3)
|
US20190030071A1
(en)
|
2014-11-03 |
2019-01-31 |
IMMURES S.r.I. |
T cell receptors
|
WO2016075099A1
(en)
|
2014-11-10 |
2016-05-19 |
Medimmune Limited |
Binding molecules specific for cd73 and uses thereof
|
WO2016075176A1
(en)
|
2014-11-11 |
2016-05-19 |
Medimmune Limited |
Therapeutic combinations comprising anti-cd73 antibodies and a2a receptor inhibitor and uses thereof
|
MA40934A
(fr)
|
2014-11-19 |
2017-09-27 |
Immunogen Inc |
Procédé de préparation de conjugués agent de liaison cellulaire-agent cytotoxique
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
WO2016115345A1
(en)
|
2015-01-14 |
2016-07-21 |
The Brigham And Women's Hospital, |
Treatment of cancer with anti-lap monoclonal antibodies
|
CN107835820B
(zh)
|
2015-01-26 |
2021-10-15 |
芝加哥大学 |
识别癌症特异性IL13Rα2的CAR T细胞
|
CN107683289B
(zh)
|
2015-01-26 |
2021-08-06 |
芝加哥大学 |
IL13Rα2结合剂和其在癌症治疗中的用途
|
SI3303395T1
(sl)
|
2015-05-29 |
2020-03-31 |
Abbvie Inc. |
Protitelesa proti CD40 in njihove uporabe
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
MX2017016647A
(es)
|
2015-06-24 |
2019-04-25 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
BR112017027254A2
(pt)
|
2015-06-29 |
2019-05-14 |
Immunogen, Inc. |
anticorpos anti-cd123 e conjugados e derivados dos mesmos
|
US10287338B2
(en)
|
2015-07-10 |
2019-05-14 |
Miran NERSISSIAN |
Factor VIII protein compositions and methods of treating of hemophilia A
|
US10940204B2
(en)
|
2015-07-31 |
2021-03-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
EP3156067A1
(de)
|
2015-10-16 |
2017-04-19 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Hpv-t-zellrezeptoren mit hoher avidität
|
PT3374398T
(pt)
|
2015-11-10 |
2020-06-16 |
Medimmune Llc |
Moléculas de ligação específicas para asct2 e suas utilizações
|
JP2019501139A
(ja)
|
2015-11-25 |
2019-01-17 |
イミュノジェン・インコーポレーテッド |
医薬製剤及びその使用
|
EP3384030A4
(de)
|
2015-12-03 |
2019-07-03 |
Trianni, Inc. |
Verbesserte immunglobulindiversität
|
US11053288B2
(en)
|
2016-02-04 |
2021-07-06 |
Trianni, Inc. |
Enhanced production of immunoglobulins
|
KR20180105233A
(ko)
|
2016-02-05 |
2018-09-27 |
이뮤노젠 아이엔씨 |
세포 결합제-세포독성제 접합체를 제조하기 위한 효율적인 방법
|
MX2018009800A
(es)
|
2016-02-12 |
2018-11-09 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista, usos de los mismos y procedimientos de identificacion de los mismos.
|
CN109153713B
(zh)
|
2016-03-10 |
2022-12-27 |
艾科赛扬制药股份有限公司 |
活化素2型受体结合蛋白及其用途
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
EP4357454A3
(de)
|
2016-03-16 |
2024-07-24 |
Immatics Biotechnologies GmbH |
Transfizierte t-zellen und t-zell-rezeptoren zur verwendung in der immuntherapie gegen krebs
|
JP7468992B2
(ja)
|
2016-03-29 |
2024-04-16 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il12及び/又は-23抗体の増加した間隔投与による乾癬の処置
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EA037960B1
(ru)
|
2016-04-27 |
2021-06-15 |
Эббви Инк. |
Способ лечения эозинофильного эзофагита с применением антитела против il-13
|
WO2017200981A1
(en)
|
2016-05-16 |
2017-11-23 |
Baxalta Incorporated |
Anti-factor ix padua antibodies
|
WO2017205747A1
(en)
|
2016-05-27 |
2017-11-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Flt3-specific chimeric antigen receptors and methods using same
|
KR20220119529A
(ko)
|
2016-06-02 |
2022-08-29 |
애브비 인코포레이티드 |
글루코코르티코이드 수용체 작용제 및 이의 면역접합체
|
CA3027044A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
BR112018075649A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
|
JP6751165B2
(ja)
|
2016-06-08 |
2020-09-02 |
アッヴィ・インコーポレイテッド |
抗b7−h3抗体及び抗体薬物コンジュゲート
|
GB201610198D0
(en)
|
2016-06-10 |
2016-07-27 |
Ucb Biopharma Sprl |
Anti-ige antibodies
|
HRP20211677T1
(hr)
|
2016-08-17 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
T-stanični receptori i imunološka terapija koja koristi iste
|
DE102016115246C5
(de)
|
2016-08-17 |
2018-12-20 |
Immatics Biotechnologies Gmbh |
Neue t-zellrezeptoren und deren verwendung in immuntherapie
|
KR20240046648A
(ko)
|
2016-09-30 |
2024-04-09 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 안전하고 효과적인 방법
|
MX2019003473A
(es)
|
2016-10-03 |
2019-10-15 |
Abbott Lab |
Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes.
|
US11249082B2
(en)
|
2016-10-29 |
2022-02-15 |
University Of Miami |
Zika virus assay systems
|
KR20240065333A
(ko)
|
2016-11-16 |
2024-05-14 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체로 건선을 치료하는 방법
|
US20230192896A1
(en)
|
2016-11-23 |
2023-06-22 |
Bioverativ Therapeutics Inc. |
Bispecific antibodies binding to coagulation factor ix and coagulation factor x
|
EP3544628A4
(de)
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1bb-bindende proteine und verwendungen davon
|
KR102375218B1
(ko)
|
2016-12-08 |
2022-03-17 |
이매틱스 바이오테크놀로지스 게엠베하 |
T 세포 수용체 및 이를 사용하는 면역 요법
|
DE102016123859B3
(de)
|
2016-12-08 |
2018-03-01 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
CA3049114A1
(en)
|
2017-01-04 |
2018-07-12 |
Lauren O. Bakaletz |
Antibody fragments for the treatment of biofilm-related disorders
|
TW201825515A
(zh)
|
2017-01-04 |
2018-07-16 |
美商伊繆諾金公司 |
Met抗體以及其免疫結合物及用途
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Dnabiiワクチンおよび強化された活性を有する抗体
|
JP7069476B2
(ja)
|
2017-01-06 |
2022-05-18 |
博奥信生物技▲術▼(南京)有限公司 |
ErbB2抗体およびその使用
|
EP3354658A1
(de)
|
2017-01-25 |
2018-08-01 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Neuartige t-zellenrezeptoren und immuntherapie damit zur behandlung von krebs und infektionskrankheiten
|
EP3573658A4
(de)
|
2017-01-30 |
2021-07-21 |
Janssen Biotech, Inc. |
Anti-tnf-antikörper, zusammensetzungen und verfahren zur behandlung von aktiver psoriatischer arthritis
|
MX2019009377A
(es)
|
2017-02-07 |
2019-12-11 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa.
|
AU2018236271B2
(en)
|
2017-03-15 |
2023-12-21 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
JP7193146B2
(ja)
|
2017-03-17 |
2022-12-20 |
国立大学法人大阪大学 |
光受容感度の抑制又は低減剤
|
DE102017106305A1
(de)
|
2017-03-23 |
2018-09-27 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapien gegen prame-positive Krebsarten
|
WO2018175942A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
CA3053409A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
BR112019022476A2
(pt)
|
2017-04-28 |
2020-05-12 |
Abbott Laboratories |
Métodos para o auxílio no diagnóstico e determinação hiperagudos de lesão cerebral traumática usando biomarcadores iniciais em pelo menos duas amostras a partir do mesmo ser humano
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
US11390683B2
(en)
|
2017-05-18 |
2022-07-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin polypeptides and proteins
|
US10866251B2
(en)
|
2017-05-25 |
2020-12-15 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
BR112019025387A2
(pt)
|
2017-05-30 |
2020-07-07 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliação de uma lesão traumática cerebral branda em um indivíduo humano com o uso de troponina cardíaca i e biomarcadores precoces
|
DE102017114737A1
(de)
|
2017-06-30 |
2019-01-03 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
CR20200076A
(es)
|
2017-07-14 |
2020-06-10 |
Pfizer |
ANTICUERPOS CONTRA MAdCAM
|
US11680110B2
(en)
|
2017-07-31 |
2023-06-20 |
Hoffmann-La Roche Inc. |
Three-dimensional structure-based humanization method
|
MX2020001328A
(es)
|
2017-08-03 |
2020-03-20 |
Amgen Inc |
Muteinas de interleucina 21 y metodos de tratamiento.
|
CA3075046A1
(en)
|
2017-09-08 |
2019-03-14 |
Amgen Inc. |
Inhibitors of kras g12c and methods of using the same
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
EP3694552A1
(de)
|
2017-10-10 |
2020-08-19 |
Tilos Therapeutics, Inc. |
Anti-lap-antikörper und verwendungen davon
|
IL308007A
(en)
|
2017-11-06 |
2023-12-01 |
Immatics Biotechnologies Gmbh |
Transgenic T-cell receptors and immunotherapy using them
|
DE102017125888A1
(de)
|
2017-11-06 |
2019-05-23 |
Immatics Biotechnologies Gmbh |
Neue konstruierte T-Zell-Rezeptoren und deren Verwendung in Immuntherapie
|
CN110892266A
(zh)
|
2017-12-09 |
2020-03-17 |
雅培实验室 |
使用gfap和uch-l1的组合辅助诊断和评价人类受试者中创伤性脑损伤的方法
|
US11022617B2
(en)
|
2017-12-09 |
2021-06-01 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
|
US20210061876A1
(en)
|
2017-12-29 |
2021-03-04 |
Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft |
T cell receptors for tumor specific proteasome splice variants and uses thereof
|
CN111727197A
(zh)
|
2018-01-12 |
2020-09-29 |
美国安进公司 |
抗pd-1抗体和治疗方法
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
CN111989117A
(zh)
|
2018-02-14 |
2020-11-24 |
维埃拉生物股份有限公司 |
麦克唐纳猫肉瘤(fms)样酪氨酸激酶3受体配体(flt3l)的抗体及其用于治疗自身免疫性疾病和炎性疾病的用途
|
IL276896B2
(en)
|
2018-03-05 |
2024-06-01 |
Janssen Biotech Inc |
Methods for treating Crohn's disease with a specific anti-IL23 antibody
|
RU2020129265A
(ru)
|
2018-03-12 |
2022-04-12 |
ЗОИТИС СЕРВИСЕЗ ЭлЭлСи |
Антитела против ngf и связанные с ними способы
|
CN108486126A
(zh)
*
|
2018-03-27 |
2018-09-04 |
重庆金迈博生物科技有限公司 |
一种核酸分子及其在人源化抗体中的应用
|
JP7269963B2
(ja)
|
2018-06-08 |
2023-05-09 |
クリスタル バイオサイエンス インコーポレイテッド |
同じ軽鎖iを有する多様な抗体を産生するためのトランスジェニック動物
|
US11830582B2
(en)
|
2018-06-14 |
2023-11-28 |
University Of Miami |
Methods of designing novel antibody mimetics for use in detecting antigens and as therapeutic agents
|
BR112020026724A2
(pt)
|
2018-07-02 |
2021-03-30 |
Amgen Inc. |
Proteína de ligação ao antígeno anti-steap1
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
EP3824295A4
(de)
|
2018-07-18 |
2022-04-27 |
Janssen Biotech, Inc. |
Prädiktoren mit verzögerter wirkung nach behandlung mit anti-il23-spezifischem antikörper
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
FI3883606T3
(fi)
|
2018-09-24 |
2023-09-07 |
Janssen Biotech Inc |
Turvallinen ja tehokas menetelmä haavaisen paksusuolitulehduksen hoitamiseksi anti-il12/il23-vasta-aineella
|
WO2020073004A1
(en)
|
2018-10-05 |
2020-04-09 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for enzymatic disruption of bacterial biofilms
|
EP3863722A2
(de)
|
2018-10-10 |
2021-08-18 |
Tilos Theapeutics, Inc. |
Anti-lap-antikörper und verwendungen davon
|
JP7463366B2
(ja)
|
2018-11-20 |
2024-04-08 |
タケダ ワクチン,インコーポレイテッド |
新規の抗ジカウイルス抗体及びその使用
|
BR112021009287A2
(pt)
|
2018-11-20 |
2021-10-26 |
Janssen Biotech, Inc. |
Método seguro e eficaz para tratar psoríase com anticorpo específico anti-il-23
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
EP3897117A1
(de)
|
2018-12-21 |
2021-10-27 |
Compass Therapeutics LLC |
Transgene maus, die eine gemeinsame menschliche leichte kette exprimiert
|
MA54750A
(fr)
|
2019-01-15 |
2021-11-24 |
Janssen Biotech Inc |
Compositions d'anticorps anti-tnf et procédés pour le traitement de l'arthrite idiopathique juvénile
|
CA3127025A1
(en)
|
2019-01-18 |
2020-07-23 |
Janssen Biotech, Inc. |
Gprc5d chimeric antigen receptors and cells expressing the same
|
MA54814A
(fr)
|
2019-01-23 |
2021-12-01 |
Janssen Biotech Inc |
Compositions d'anticorps anti-tnf destinées à être utilisées dans des méthodes de traitement d'arthrite psoriasique
|
KR20210141990A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생성하기 위한 제조 방법
|
EP3938391A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
US20220153830A1
(en)
|
2019-03-14 |
2022-05-19 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
MA55284A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de production de compositions d'anticorps anti-tnf
|
EP3941934A4
(de)
|
2019-03-18 |
2022-12-07 |
Janssen Biotech, Inc. |
Verfahren zur behandlung von psoriasis bei kindern mit anti-il12/il23-antikörper
|
AU2020271123A1
(en)
|
2019-04-10 |
2021-11-25 |
Elevatebio Technologies, Inc. |
FLT3-specific chimeric antigen receptors and methods of using the same
|
JP2022534020A
(ja)
|
2019-05-23 |
2022-07-27 |
ヤンセン バイオテツク,インコーポレーテツド |
Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
WO2020245677A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
AU2020289070A1
(en)
|
2019-06-03 |
2022-02-03 |
Janssen Biotech, Inc. |
Anti-TNF antibody compositions, and methods for the treatment of Psoriatic Arthritis
|
KR20220032066A
(ko)
|
2019-07-08 |
2022-03-15 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
생물막을 파괴하기 위한 항체 조성물
|
AU2020322221A1
(en)
|
2019-07-26 |
2022-03-24 |
Janssen Biotech, Inc. |
Anti-hK2 chimeric antigen receptor (CAR)
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
JP2023502652A
(ja)
|
2019-11-18 |
2023-01-25 |
ヤンセン バイオテツク,インコーポレーテツド |
抗cd79キメラ抗原受容体、car-t細胞、及びそれらの使用
|
WO2021119012A1
(en)
|
2019-12-09 |
2021-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF
|
EP4077376A2
(de)
|
2019-12-19 |
2022-10-26 |
Quidel Corporation |
Monoklonale antikörperfusionen
|
CN115397848A
(zh)
|
2020-02-05 |
2022-11-25 |
拉利玛生物医药公司 |
Tat肽结合蛋白及其用途
|
WO2021207449A1
(en)
|
2020-04-09 |
2021-10-14 |
Merck Sharp & Dohme Corp. |
Affinity matured anti-lap antibodies and uses thereof
|
CA3175523A1
(en)
|
2020-04-13 |
2021-10-21 |
Antti Virtanen |
Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample
|
CN115803062A
(zh)
|
2020-06-03 |
2023-03-14 |
博泰康医药公司 |
滋养层细胞表面抗原2(trop-2)抗体
|
BR112022025026A2
(pt)
|
2020-06-08 |
2023-02-14 |
Janssen Biotech Inc |
Ensaio baseado em células para determinar atividade de morte tumoral in vitro de células imunitárias que expressam antigénio quimérico
|
US20230256114A1
(en)
|
2020-07-07 |
2023-08-17 |
Bionecure Therapeutics, Inc. |
Novel maytansinoids as adc payloads and their use for the treatment of cancer
|
CN115803347A
(zh)
|
2020-07-17 |
2023-03-14 |
詹森生物科技公司 |
抗klk2抗体的抗独特型抗体
|
EP4225801A1
(de)
|
2020-07-17 |
2023-08-16 |
Janssen Biotech, Inc. |
Antiidiotypische antikörper gegen anti-gprc5d-antikörper
|
JP2023534987A
(ja)
|
2020-07-24 |
2023-08-15 |
アムジエン・インコーポレーテツド |
Sars-cov2スパイクタンパク質に由来する免疫原
|
US11988671B2
(en)
|
2020-08-04 |
2024-05-21 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting SARS-CoV-2
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
CR20230146A
(es)
|
2020-09-11 |
2023-06-07 |
Medimmune Ltd |
Moléculas de unión a b7-h4 terapéuticas
|
WO2022053685A2
(en)
|
2020-09-12 |
2022-03-17 |
Medimmune Limited |
A scoring method for an anti-b7h4 antibody-drug conjugate therapy
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
JP2024506694A
(ja)
|
2021-02-16 |
2024-02-14 |
ヤンセン バイオテツク,インコーポレーテツド |
増強されたリンカー標的化のための材料及び方法
|
MX2023010697A
(es)
|
2021-03-12 |
2023-11-23 |
Janssen Biotech Inc |
Método para tratar pacientes con artritis psoriásica con respuesta inadecuada a la terapia de tnf con anticuerpo específico anti-il23.
|
KR20230156387A
(ko)
|
2021-03-12 |
2023-11-14 |
얀센 바이오테크 인코포레이티드 |
항-il23 특이적 항체에 의해 건선성 관절염을 치료하는 안전하고 효과적인 방법
|
EP4308603A1
(de)
|
2021-03-17 |
2024-01-24 |
Receptos Llc |
Verfahren zur behandlung von atopischer dermatitis mit anti-il-13-antikörpern
|
EP4308607A2
(de)
|
2021-03-18 |
2024-01-24 |
MedImmune Limited |
An ccr9 bindendes therapeutisches bindungsmolekül
|
EP4067371A1
(de)
|
2021-03-31 |
2022-10-05 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Für hepatitis-c-virus-peptide spezifische t-zell-rezeptoren
|
EP4079753A1
(de)
|
2021-04-20 |
2022-10-26 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
T-zell-rezeptoren spezifisch für sowohl rac1- als auch rac2-abgeleitete mutierte epitope
|
EP4323389A1
(de)
|
2021-04-15 |
2024-02-21 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
T-zell-rezeptoren, die für sowohl von rac1- als auch von rac2-abgeleiteten mutierten epitopen spezifisch sind
|
WO2022241057A1
(en)
|
2021-05-12 |
2022-11-17 |
Applied Biomedical Science Institute |
Binding polypeptides against sars cov-2 and uses thereof
|
EP4341699A1
(de)
|
2021-05-18 |
2024-03-27 |
Abbott Laboratories |
Verfahren zur beurteilung von hirnläsionen bei einem pädiatrischen patienten
|
AU2022276189A1
(en)
|
2021-05-20 |
2024-01-18 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
WO2022254292A1
(en)
|
2021-06-01 |
2022-12-08 |
Janssen Biotech, Inc. |
Anti-idiotypic antibodies against anti-cd79b antibodies
|
US20240118279A1
(en)
|
2021-06-14 |
2024-04-11 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
CN118139883A
(zh)
|
2021-07-09 |
2024-06-04 |
詹森生物科技公司 |
用于生产抗tnf抗体组合物的制造方法
|
KR20240032991A
(ko)
|
2021-07-09 |
2024-03-12 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물의 생성을 위한 제조 방법
|
AU2022306973A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-il12/il23 antibody compositions
|
US11807685B2
(en)
|
2021-08-05 |
2023-11-07 |
The Uab Research Foundation |
Anti-CD47 antibody and uses thereof
|
CA3230038A1
(en)
|
2021-08-31 |
2023-03-09 |
Hongwei Zhang |
Methods and systems of diagnosing brain injury
|
CN118451103A
(zh)
|
2021-09-03 |
2024-08-06 |
伯尔尼大学 |
用于治疗长qt综合征的组合物和方法
|
AU2022354059A1
(en)
|
2021-09-30 |
2024-03-28 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023077343A1
(en)
|
2021-11-04 |
2023-05-11 |
Janssen Biotech, Inc. |
Bcma-targeted car-t cell therapy for multiple myeloma
|
CN118510801A
(zh)
|
2021-11-04 |
2024-08-16 |
詹森生物科技公司 |
用于多发性骨髓瘤的靶向bcma的car-t细胞疗法
|
CA3238377A1
(en)
|
2021-11-15 |
2023-05-19 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023095000A1
(en)
|
2021-11-23 |
2023-06-01 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|
CA3240822A1
(en)
|
2021-12-17 |
2023-06-22 |
Tony Lee |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
EP4223782A1
(de)
|
2022-02-07 |
2023-08-09 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Neuartige t-zell-rezeptoren und immuntherapie damit zur behandlung von krebs und infektionskrankheiten
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
US20230312703A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of Treating Psoriasis with IL-23 Specific Antibody
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024050526A1
(en)
|
2022-09-02 |
2024-03-07 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for treating long qt syndrome
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024110898A1
(en)
|
2022-11-22 |
2024-05-30 |
Janssen Biotech, Inc. |
Method of treating ulcerative colitis with anti-il23 specific antibody
|